Charles River Laboratories International, Inc.
CRL
$162.85
-$5.84-3.46%
NYSE
| 03/28/2026 | 12/27/2025 | 09/27/2025 | 06/28/2025 | 03/29/2025 | |
|---|---|---|---|---|---|
| Net Income | -14.84M | -276.56M | 54.42M | 52.33M | 25.47M |
| Total Depreciation and Amortization | 67.15M | 124.78M | 14.16M | 155.01M | 78.66M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 94.85M | 292.53M | 150.39M | -13.90M | 66.28M |
| Change in Net Operating Assets | -106.08M | 6.77M | -5.15M | 11.17M | 1.29M |
| Cash from Operations | 41.08M | 147.52M | 213.83M | 204.60M | 171.70M |
| Capital Expenditure | -55.91M | -88.95M | -35.58M | -35.30M | -59.32M |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -405.01M | -- | -- | -- | -- |
| Divestitures | 60.10M | 0.00 | 0.00 | 0.00 | 17.44M |
| Other Investing Activities | -7.03M | -3.86M | 1.88M | -2.04M | -3.60M |
| Cash from Investing | -407.85M | -92.81M | -33.70M | -37.34M | -45.48M |
| Total Debt Issued | 912.46M | 156.67M | 107.50M | 547.02M | 416.34M |
| Total Debt Repaid | -355.68M | -207.82M | -253.79M | -738.31M | -149.39M |
| Issuance of Common Stock | 1.22M | 711.00K | 2.00K | 1.00K | -- |
| Repurchase of Common Stock | -208.29M | -96.00K | -93.00K | -7.35M | -353.13M |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -2.00M | -1.34M | -6.23M | -28.28M | -19.14M |
| Cash from Financing | 347.72M | -51.86M | -152.62M | -226.92M | -105.33M |
| Foreign Exchange rate Adjustments | 1.25M | 3.93M | -3.03M | 12.67M | 5.27M |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -17.80M | 6.78M | 24.48M | -46.99M | 26.16M |